Ask AI
MANIFEST 2 96 Wk Update
MANIFEST-2 96-Wk Update: Ruxolitinib + Pelabresib or Placebo in Patients With JAK Inhibitor–Naive MF

Released: December 12, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 12, 2025